Barclays’s National Health Investors NHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93M | Sell |
23,908
-53,088
| -69% | -$4.42M | ﹤0.01% | 2374 |
|
|
2025
Q4 | $5.88M | Buy |
76,996
+10,060
| +15% | +$771K | ﹤0.01% | 2091 |
|
|
2025
Q3 | $5.32M | Sell |
66,936
-22,405
| -25% | -$1.68M | ﹤0.01% | 2150 |
|
|
2025
Q2 | $6.26M | Buy |
89,341
+28,969
| +48% | +$2.12M | ﹤0.01% | 1926 |
|
|
2025
Q1 | $4.46M | Sell |
60,372
-16,750
| -22% | -$1.18M | ﹤0.01% | 2001 |
|
|
2024
Q4 | $5.34M | Buy |
77,122
+5,419
| +8% | +$412K | ﹤0.01% | 2094 |
|
|
2024
Q3 | $6.03M | Buy |
71,703
+54,782
| +324% | +$4.22M | ﹤0.01% | 1923 |
|
|
2024
Q2 | $1.15M | Sell |
16,921
-22,503
| -57% | -$1.44M | ﹤0.01% | 2520 |
|
|
2024
Q1 | $2.48M | Sell |
39,424
-29,516
| -43% | -$1.66M | ﹤0.01% | 2394 |
|
|
2023
Q4 | $3.85M | Buy |
68,940
+49,466
| +254% | +$2.62M | ﹤0.01% | 2352 |
|
|
2023
Q3 | $1M | Sell |
19,474
-87,485
| -82% | -$4.58M | ﹤0.01% | 2336 |
|
|
2023
Q2 | $5.61M | Sell |
106,959
-5,054
| -5% | -$260K | ﹤0.01% | 1284 |
|
|
2023
Q1 | $5.78M | Sell |
112,013
-55,625
| -33% | -$3.03M | ﹤0.01% | 1446 |
|
|
2022
Q4 | $8.75M | Buy |
167,638
+9,701
| +6% | +$532K | ﹤0.01% | 1269 |
|
|
2022
Q3 | $8.93M | Buy |
157,937
+95,768
| +154% | +$6.04M | 0.01% | 898 |
|
|
2022
Q2 | $3.77M | Buy |
62,169
+52,186
| +523% | +$2.97M | ﹤0.01% | 1484 |
|
|
2022
Q1 | $589K | Sell |
9,983
-94,285
| -90% | -$5.37M | ﹤0.01% | 2787 |
|
|
2021
Q4 | $5.99M | Sell |
104,268
-2,430
| -2% | -$134K | ﹤0.01% | 1573 |
|
|
2021
Q3 | $5.71M | Buy |
106,698
+66,476
| +165% | +$4.15M | ﹤0.01% | 1536 |
|
|
2021
Q2 | $2.7M | Sell |
40,222
-54,257
| -57% | -$3.78M | ﹤0.01% | 1990 |
|
|
2021
Q1 | $6.83M | Buy |
94,479
+64,766
| +218% | +$4.52M | ﹤0.01% | 1275 |
|
|
2020
Q4 | $2.06M | Sell |
29,713
-9,192
| -24% | -$584K | ﹤0.01% | 2215 |
|
|
2020
Q3 | $2.35M | Sell |
38,905
-7,893
| -17% | -$487K | ﹤0.01% | 1966 |
|
|
2020
Q2 | $2.84M | Buy |
46,798
+23,786
| +103% | +$1.31M | ﹤0.01% | 1801 |
|
|
2020
Q1 | $1.14M | Sell |
23,012
-29,225
| -56% | -$2.22M | ﹤0.01% | 2821 |
|
|
2019
Q4 | $4.26M | Buy |
52,237
+9,845
| +23% | +$806K | ﹤0.01% | 2181 |
|
|
2019
Q3 | $3.49M | Buy |
42,392
+4,049
| +11% | +$329K | ﹤0.01% | 2213 |
|
|
2019
Q2 | $2.99M | Sell |
38,343
-5,296
| -12% | -$412K | ﹤0.01% | 2443 |
|
|
2019
Q1 | $3.43M | Buy |
43,639
+16,191
| +59% | +$1.29M | ﹤0.01% | 2008 |
|
|
2018
Q4 | $2.08M | Sell |
27,448
-16,246
| -37% | -$1.22M | ﹤0.01% | 2375 |
|
|
2018
Q3 | $3.3M | Buy |
43,694
+5,453
| +14% | +$416K | ﹤0.01% | 2281 |
|
|
2018
Q2 | $2.82M | Buy |
38,241
+11,706
| +44% | +$827K | ﹤0.01% | 2247 |
|
|
2018
Q1 | $1.78M | Buy |
26,535
+14,059
| +113% | +$961K | ﹤0.01% | 2577 |
|
|
2017
Q4 | $941K | Buy |
12,476
+5,758
| +86% | +$447K | ﹤0.01% | 3174 |
|
|
2017
Q3 | $519K | Buy |
6,718
+3,726
| +125% | +$291K | ﹤0.01% | 3587 |
|
|
2017
Q2 | $237K | Sell |
2,992
-4,056
| -58% | -$307K | ﹤0.01% | 4224 |
|
|
2017
Q1 | $512K | Sell |
7,048
-2,699
| -28% | -$198K | ﹤0.01% | 3385 |
|
|
2016
Q4 | $724K | Buy |
9,747
+3,171
| +48% | +$233K | ﹤0.01% | 3044 |
|
|
2016
Q3 | $516K | Sell |
6,576
-2,106
| -24% | -$166K | ﹤0.01% | 3193 |
|
|
2016
Q2 | $652K | Buy |
8,682
+3,426
| +65% | +$238K | ﹤0.01% | 2978 |
|
|
2016
Q1 | $347K | Buy |
5,256
+1,912
| +57% | +$118K | ﹤0.01% | 3427 |
|
|
2015
Q4 | $201K | Sell |
3,344
-622
| -16% | -$37.1K | ﹤0.01% | 3898 |
|
|
2015
Q3 | $227K | Sell |
3,966
-8,380
| -68% | -$507K | ﹤0.01% | 4051 |
|
|
2015
Q2 | $766K | Sell |
12,346
-14,952
| -55% | -$1,000K | ﹤0.01% | 3114 |
|
|
2015
Q1 | $1.94M | Sell |
27,298
-21,850
| -44% | -$1.58M | ﹤0.01% | 2351 |
|
|
2014
Q4 | $3.39M | Buy |
49,148
+23,010
| +88% | +$1.49M | ﹤0.01% | 2040 |
|
|
2014
Q3 | $1.49M | Sell |
26,138
-3,959
| -13% | -$245K | ﹤0.01% | 2946 |
|
|
2014
Q2 | $1.86M | Buy |
30,097
+20,044
| +199% | +$1.24M | ﹤0.01% | 2678 |
|
|
2014
Q1 | $603K | Sell |
10,053
-4,049
| -29% | -$246K | ﹤0.01% | 3768 |
|
|
2013
Q4 | $790K | Buy |
14,102
+2,250
| +19% | +$134K | ﹤0.01% | 3642 |
|
|
2013
Q3 | $664K | Sell |
11,852
-664
| -5% | -$39.6K | ﹤0.01% | 3795 |
|
|
2013
Q2 | $749K | Buy |
+12,516
| New | +$811K | ﹤0.01% | 3735 |
|
Other funds holding NHI
VPM
VCM
NAMI
Barclays's NHI Position: Q1 2026 in Review
Barclays reduced its National Health Investors (NHI) stake by 69% in Q1 2026, selling an estimated $4.42M and leaving 23,908 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2374.
Barclays first reported a position in NHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.93M in Q3 2022. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.
- Barclays held 23,908 shares of National Health Investors worth $1.93M as of Q1 2026.
- Barclays sold 53,088 National Health Investors shares in Q1 2026, an estimated $4.42M.
- National Health Investors made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2374 holding.
- Barclays first reported a position in National Health Investors in Q2 2013 and has held it in 52 quarters since.
- Barclays's National Health Investors position peaked at $8.93M in Q3 2022.
- 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.